184 related articles for article (PubMed ID: 36893901)
1. NF-κB/c-Rel DNA-binding is reduced in substantia nigra and peripheral blood mononuclear cells of Parkinson's disease patients.
Porrini V; Pilotto A; Vezzoli M; Lanzillotta A; Gennari MM; Bonacina S; Alberici A; Turrone R; Bellucci A; Antonini A; Padovani A; Pizzi M
Neurobiol Dis; 2023 May; 180():106067. PubMed ID: 36893901
[TBL] [Abstract][Full Text] [Related]
2. Pro-survival and anti-inflammatory roles of NF-κB c-Rel in the Parkinson's disease models.
Wang Z; Dong H; Wang J; Huang Y; Zhang X; Tang Y; Li Q; Liu Z; Ma Y; Tong J; Huang L; Fei J; Yu M; Wang J; Huang F
Redox Biol; 2020 Feb; 30():101427. PubMed ID: 31986466
[TBL] [Abstract][Full Text] [Related]
3. NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice.
Parrella E; Bellucci A; Porrini V; Benarese M; Lanzillotta A; Faustini G; Longhena F; Abate G; Uberti D; Pizzi M
Transl Neurodegener; 2019; 8():16. PubMed ID: 31139367
[TBL] [Abstract][Full Text] [Related]
4. Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease.
Bellucci A; Bubacco L; Longhena F; Parrella E; Faustini G; Porrini V; Bono F; Missale C; Pizzi M
Front Aging Neurosci; 2020; 12():68. PubMed ID: 32265684
[TBL] [Abstract][Full Text] [Related]
5. Mild Inflammatory Profile without Gliosis in the c-Rel Deficient Mouse Modeling a Late-Onset Parkinsonism.
Porrini V; Mota M; Parrella E; Bellucci A; Benarese M; Faggi L; Tonin P; Spano PF; Pizzi M
Front Aging Neurosci; 2017; 9():229. PubMed ID: 28769786
[TBL] [Abstract][Full Text] [Related]
6. RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.
Pranski EL; Dalal NV; Sanford CV; Herskowitz JH; Gearing M; Lazo C; Miller GW; Lah JJ; Levey AI; Betarbet RS
Neurobiol Dis; 2013 Jun; 54():264-79. PubMed ID: 23318928
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
[TBL] [Abstract][Full Text] [Related]
8. Late-onset Parkinsonism in NFκB/c-Rel-deficient mice.
Baiguera C; Alghisi M; Pinna A; Bellucci A; De Luca MA; Frau L; Morelli M; Ingrassia R; Benarese M; Porrini V; Pellitteri M; Bertini G; Fabene PF; Sigala S; Spillantini MG; Liou HC; Spano PF; Pizzi M
Brain; 2012 Sep; 135(Pt 9):2750-65. PubMed ID: 22915735
[TBL] [Abstract][Full Text] [Related]
9. Genetic suppression of IKK2/NF-κB in astrocytes inhibits neuroinflammation and reduces neuronal loss in the MPTP-Probenecid model of Parkinson's disease.
Kirkley KS; Popichak KA; Hammond SL; Davies C; Hunt L; Tjalkens RB
Neurobiol Dis; 2019 Jul; 127():193-209. PubMed ID: 30818064
[TBL] [Abstract][Full Text] [Related]
10. Alteration of nuclear factor-kappaB pathway promote neuroinflammation depending on the functions of estrogen receptors in substantia nigra after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Mitra S; Ghosh N; Sinha P; Chakrabarti N; Bhattacharyya A
Neurosci Lett; 2016 Mar; 616():86-92. PubMed ID: 26827723
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
13. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
14. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression.
Bourdenx M; Dovero S; Engeln M; Bido S; Bastide MF; Dutheil N; Vollenweider I; Baud L; Piron C; Grouthier V; Boraud T; Porras G; Li Q; Baekelandt V; Scheller D; Michel A; Fernagut PO; Georges F; Courtine G; Bezard E; Dehay B
Acta Neuropathol Commun; 2015 Jul; 3():46. PubMed ID: 26205255
[TBL] [Abstract][Full Text] [Related]
15. EriB targeted inhibition of microglia activity attenuates MPP
Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
[TBL] [Abstract][Full Text] [Related]
16. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
17. PAR2-mediated epigenetic upregulation of α-synuclein contributes to the pathogenesis of Parkinson׳s disease.
Liu P; Sun L; Zhao XL; Zhang P; Zhao XM; Zhang J
Brain Res; 2014 May; 1565():82-9. PubMed ID: 24747612
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
19. Cell type- and region-specific translatomes in an MPTP mouse model of Parkinson's disease.
Huang Q; Chen C; Chen W; Cai C; Xing H; Li J; Li M; Ma S
Neurobiol Dis; 2023 May; 180():106105. PubMed ID: 36977454
[TBL] [Abstract][Full Text] [Related]
20. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
